Top Section/Ad
Top Section/Ad
Most recent
Naturgy and Zurich fall in secondary market after jumbo blocks
Capital raise and investor selldown follow €3bn raise by Engie on Friday evening
UKPN purchase seen as positive by rating agencies, leads to senior and hybrid upgrades
More articles/Ad
More articles/Ad
More articles
-
Geopolitical risk will likely continue to determine investor appetite for EMEA equity capital markets transactions but investors insist deals can be done regardless as long as the discount is sufficient. -
A benign start to the year for major equity indices could be just the comfort blocks bankers need to price deals before corporate blackouts begin.
-
Equity block trade bankers in EMEA are girding themselves for a tough 2019, in which market conditions could be at least as difficult as the tricky ones they dealt with in 2018.
-
Volatility has returned to equity capital markets, derailing indices and making new capital raising much more difficult. ECM deals can still offer investors a way to outperform, but when markets are tough, their risk appetite shrivels. Many political shocks could hurt in 2019, starting with Brexit and a global trade war. But overshadowing all this is the fear that a more profound pessimism has returned to stalk equity markets, after their long upward decade. Sam Kerr reports.
-
Santhera Pharmaceuticals, the Swiss speciality pharmaceuticals company, has launched a Sfr77m fundraising following the release of its latest earnings statement on Wednesday morning.
-
Nicholas Chia has left OCBC to join CLSA as the Citic Securities-owned brokerage looks to build out its southeast Asia equity capital markets franchise.
